If you’re thinking about fertility treatment today—whether just starting to explore options or already in the middle of your journey—you’re entering a highly innovative, rapidly evolving area of modern medicine. That progress matters because the experience, decisions, and outcomes patients face today look very different from just a few years ago, and those advances are actively working in your favor.
Infertility affects 1 in 6 people worldwide, and as we acknowledged last month for National Infertility Awareness Week (NIAW) – and every April during NIAW – behind that statistic are individuals and couples making deeply personal decisions about how to achieve the family of their dreams. While it’s critical to dispel myths and misinformation about infertility, and help those struggling with infertility to find community, it’s also important for individuals and couples to know about the exciting work that will help them on their path to parenthood. Fertility medicine is evolving to meet this growing need with greater precision, deeper personalization, and more support throughout the journey. This evolution reflects the dedication of the reproductive endocrinologists, embryologists and care teams working to support patients, along with steady advances in technology, clinical care models, and access that are reshaping outcomes and personalizing experiences for the millions who rely on it to build their families.
Here are five of the most important breakthroughs shaping the field today.
1) Smarter Technology
Every step in the IVF process—from embryo selection to transfer timing—depends on careful decision-making. Advances in technology now give clinicians more detailed and actionable information at each stage.
Pre-implantation genetic testing for aneuploidy (PGT-A) of embryos has helped identify embryos with the highest likelihood of leading to a healthy pregnancy and has contributed to safer single-embryo transfer practices, reducing the need to transfer multiple embryos at once.
What has changed in recent years is how these results are interpreted. PGT-A is now understood with more nuance. For example, IVI RMA research presented at the American Society for Reproductive Medicine (ASRM) 2025 Scientific Congress investigated the reproductive potential of segmental aneuploid embryos – embryos with partial gains or losses of chromosomal material. This work helps better inform clinical interpretation of genetic testing results and may reduce the number of embryos that are unnecessarily excluded from transfer consideration.
Better vitrification has been another major step forward. The ability to rapidly freeze embryos has made “freeze-all” strategies much more practical. This gives clinicians flexibility to transfer embryos at the right time instead of being tied to a single cycle, which can improve outcomes and make the process easier for patients.
Finally, there have also been steady improvements in blastocyst culture which make it easier to grow embryos to later stages, where selection before transfer is more predictive. Better integration of data across lab systems, genetic testing, and clinical outcomes is also creating a feedback loop that helps clinics refine their processes over time and better serve patients.
2) Automation
Automation is helping IVF laboratories become more standardized and secure. Advanced tracking and witnessing systems, like those made by TMRW Life Sciences, reduce the risk of sample mix-ups and add an additional layer of safety as clinics handle more cycles.
Automation is also improving consistency in embryo evaluation. AI-based grading tools are starting to support more standardized decisions in areas that once relied heavily on individual interpretation by embryologists. Time-lapse incubators are also becoming more commonly used in leading clinics, allowing embryos to develop in stable conditions while being monitored continuously without disruption.
3) More Powerful Diagnostics
A better understanding of infertility itself is also driving progress. Estimated to be the cause in roughly one third of infertility diagnoses, there is now greater attention on male factor infertility, and there are early applications of AI in sperm and egg quality assessment, which have traditionally been harder to evaluate. At the same time, the field is moving toward non-invasive embryo testing methods. These approaches analyze the surrounding culture media rather than taking a biopsy, which could make testing safer and less disruptive.
For female patients, monitoring has become much more precise. Advances in imaging and hormone tracking allow clinicians to better understand ovarian response and follicle development. This leads to more effective and individualized treatment plans. At the same time, new approaches to evaluating endometrial receptivity are helping determine the best timing for embryo transfer.
4) More Informed, Personalized Clinical Care
Clinical care is becoming more individualized as better data becomes available. By analyzing large datasets, clinics can better estimate outcomes and tailor patient treatments accordingly.
Stimulation protocols are also no longer one-size-fits-all. They are increasingly tailored to each patient’s biology, medical history, and goals. This approach can help reduce risks while improving the chances of retrieving high-quality eggs.
AI and data analytics are also starting to support clinical decisions more directly. From medication dosing to timing embryo transfers, clinicians can draw on insights from large numbers of past cases rather than relying only on experience.
There is also a shift in how success is measured. Instead of focusing only on results from a single cycle, clinics are looking at cumulative outcomes over multiple cycles. This broader view better reflects how patients actually go through treatment and leads to more thoughtful care planning.
5) End-to-End Support and Access
Finally, the way fertility care is delivered is changing. The industry is moving toward more integrated models that combine clinical care, financing, and patient support. Partnerships such as the collaboration between Costco, Sesame, and IVI RMA point to a future where fertility services are easier to access and navigate through a streamlined and guided pathway.
There is also more recognition of the emotional side of fertility treatment. Many clinics are expanding mental health support and offering more holistic care and counseling as part of their treatment plans. Stress is increasingly seen as something that can affect outcomes, not just an unavoidable part of the process.
Digital tools are improving how patients engage with care. Apps, messaging platforms, and AI assistants help patients stay informed, manage medications, and get answers quickly. Together these tools can make a complex process feel more manageable.
The field of fertility is also becoming more inclusive. There is growing support for LGBTQ+ patients, single parents by choice, and people pursuing elective fertility preservation. Fertility care is expanding to reflect a wider range of paths to building a family, and better fertility clinic integration with surrogacy services and cryobanks ensure patients have quick access to all the tools they need.
The Bottom Line
Together, these changes reflect a broader shift in fertility medicine and can offer hope to the 1 in 6 people struggling with infertility as the field crosses the threshold of 100,000 babies born in a single year in the U.S. through IVF. The field is becoming more coordinated, more data-driven, and more focused on patients’ experience. As these trends continue, the biggest improvements won’t just be in success rates, but in making fertility care more accessible, understandable, and aligned with what patients need.
